On Wednesday, the Food and Drug Administration authorize the first subvariant-specific "redesign" of the COVID-19 vaccine, with the rollout projected to begin as early as next week.
Each day, the U.S. records an average of 90,000 new infections of COVID-19 and 475 new deaths, largely driven by the COVID-19 Omicron subvariants BA.4 and...
